Effects of Empagliflozin on Cardiac Microvasculature and Insulin Sensitivity in Subjects With Type 2 Diabetes
Clinical trial NCT04203927 · UNKNOWN
Trial details
- NCT number
- NCT04203927
- Sponsor
- University of Virginia
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-01
- Primary completion
- 2023-10-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.